Nykode Therapeutics Announces Collaboration with The GOG : v

Potentially registrational VB-C-04 trial in the U.S. expected to initiate 4Q 2023The GOG Foundation, Inc. (GOG) is a U.S. based not-for-profit organization...

Related Keywords

United States , Oslo , Norway , Klaus Edvardsen , Nykode Vaccibody , Leslie Randall , Michael Engsig , Agnete Fredriksen , Genentech , David Geffen School Of Medicine , Roche Group , Foundation Inc , Division Of Gynecologic Oncology , Oslo Stock Exchange , Chief Development Officer , Chief Executive Officer , Nykode Therapeutics , Cervical Cancer Advisor , Ritu Salani , Gynecologic Oncology , David Geffen School , Antigen Presenting Cells , Adaptive Biotechnologies , Business Officer , Oslo Stock Exchange Nykd ,